Boehringer & Sleip Partner for AI-Based Horse Lameness Detection

The new global business partnership between Boehringer Ingelheim and Slape will expand access to AI to improve the detection, diagnosis and treatment of lameness in horses. This collaboration will enable Boehringer and Sleip to offer innovative solutions to help veterinary professionals continue to advance their practice and improve the care and welfare of horses.

Gait changes and lameness symptoms may be less noticeable and difficult to detect. The Sleip app can help you make a real difference. Vets can use smartphones to record horse behavior without sophisticated sensors and camera systems. Sleip's AI-powered technology analyzes your horse's movements and displays the results in the app within minutes, including gait analysis video and real-time biometric data. Your veterinarian can continue to monitor your horse's health.

"Our goal is to better serve the veterinary community. The Sleip app will help increase horse health and increase diagnosis. Treatment and treatment," says Boehringer Ingelheim of Boehringer Ingelheim. Saskia Kley, global CEO of Equine. "With this new technology, we can have a better outcome for the lives of horses and those who care for them."

"Sleip uses decades of research in equine biomechanics and advances in artificial intelligence to help us understand how horses move," says Elin Hernlund, DVM, PhD and Sleip's medical director. "Our vision is to improve horse health by offering Sleip's technology to everyone who cares for horses. The goal is to support early detection and prevention by improving rather than diagnosing and collaboratively promoting the health of each horse. We are very excited to work with Boehringer on this project.